Meeting
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
Authors
Nicole Grace Chau
Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Nicole Grace Chau , Yvonne Y Li , Yin P. Hung , Peter S. Hammerman , Scott J. Rodig , Jonathan Daniel Schoenfeld , Danielle Nina Margalit , Jochen H. Lorch , Guilherme Rabinowits , Roy B. Tishler , Robert I. Haddad , Vickie Y. Jo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6052)
DOI
10.1200/JCO.2016.34.15_suppl.6052
Abstract #
6052
Poster Bd #
374
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Examination of the tumor immune microenvironment (TIME) with multispectral immunofluorescence (m-IF): Association of markers with prognosis and bevacizumab (bev) benefit in NRG Oncology/NSABP C-08.
First Author: Katherine L. Pogue-Geile
Poster
2017 Genitourinary Cancers Symposium
Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Jean-Christophe Pignon
Poster
2016 ASCO Annual Meeting
Association of methylation of homologous repair genes with expression of immune checkpoints in squamous cell carcinoma of head and neck, lung and cervix.
First Author: Damian Tobias Rieke
Poster
2022 ASCO Annual Meeting
Immune tumor microenvironnement (iTME) post-neoadjuvant chemotherapy, beyond PD-L1: Novel immune targets in ovarian cancer, data from the CHIVA trial, a GINECO/GINEGEPS study.
First Author: Felix Blanc-Durand